查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585667

生物义肢市场：按类型、应用分类 - 2025-2030 年全球预测

Bioprosthetics Market by Type (Allograft, Bovine, Porcine), Application (Cardiovascular, Plastic Surgery & Wound Healing) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物义肢市场价值为59.7亿美元，预计2024年将达到71.4亿美元，复合年增长率为19.61%，到2030年将达到209.4亿美元。

生物假体包括由生物材料製成的医疗植入部分，旨在替换或修復受损的组织或器官。这种需求源自于退化性疾病、创伤和先天缺陷等问题，导致人们需要比传统材料更相容且更不易排斥的替代品。应用主要包括心血管手术，特别是心臟瓣膜、疝气修復和其他软组织重组。最终使用领域包括医院、专科诊所和门诊手术中心，其中的挑战始终是透过先进的手术选择来改善病患的治疗效果。主要成长动力包括心血管疾病盛行率的增加、生物相容性的进步以及人口老化。由于对医疗基础设施发展的日益关注以及患者对先进治疗方案的认识，新兴市场具有巨大潜力。然而，与生物材料的使用相关的高成本、严格的法规环境和伦理问题等限制因素可能会阻碍市场的进步。同样具有挑战性的是开发人员必须克服合成替代品日益激烈的竞争和技术限制。组织工程、提高材料的生物相容性以及整合数位健康工具的组合设备等领域的创新可以为业务成长提供利润丰厚的机会。提高耐久性和降低免疫抗原性的研究对于扩大市场接受度和适用性至关重要。市场本质上是动态的，受到全球监管变化和技术进步的推动。公司应投资于尖端生物修復解决方案的研发，并与医疗保健提供者合作，以确保产品符合当前和新兴的需求。透过临床试验提高意识并证明安全性和有效性是巩固市场地位的重要策略。

主要市场统计
基准年[2023] 59.7亿美元
预测年份 [2024] 71.4亿美元
预测年份 [2030] 209.4亿美元
复合年增长率（%） 19.61%

市场动态：揭示快速发展的生物修復市场的关键市场洞察

供需的动态交互作用正在改变生物义肢市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人群中心血管疾病盛行率上升
    • 各国医疗保健支出增加
    • 生物义肢在整形外科和创伤治疗过程中的重要应用
  • 市场限制因素
    • 生物假体手术相关的高成本
  • 市场机会
    • 组织工程生物假体的技术进步与快速发展
    • 新的资金筹措活动促进研发活动
  • 市场挑战
    • 阀门耐用性和相容性问题

波特的五力：驾驭生物义肢市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物义肢市场的外部影响

外部宏观环境因素在塑造生物义肢市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生物义肢市场的竞争状况

对生物义肢市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生物义肢市场供应商绩效评估

FPNV定位矩阵是评估生物义肢市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了生物义肢市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对生物义肢市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人群中心血管疾病盛行率上升
      • 经济体中的医疗成本增加
      • 生物义肢在整形外科手术和创伤治疗过程中的重要应用
    • 抑制因素
      • 生物假体手术相关的高成本
    • 机会
      • 组织工程人工替代物体的技术进步与快速发展
      • 新的资金筹措努力促进研发活动
    • 任务
      • 阀门耐用性和相容性问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物义肢市场：依类型

  • 同种异体移植
  • 牛
  • 猪肉
  • 异种移植

第七章生物义肢市场：依应用分类

  • 心血管
  • 整形外科和创伤治疗

第八章北美和南美生物修復市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区生物修復市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的生物义肢市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Anteris Technologies Ltd.
  • Aortech International PLC
  • Boston Scientific Corporation
  • Braile Biomedica, Inc.
  • Corcym UK Limited
  • Edwards Lifesciences Corporation
  • Foldax
  • Getinge AB
  • Hancock Jaffe Laboratories, Inc.
  • Humacyte, Inc.
  • JenaValve Technology GmbH
  • Labcor Laboratorios Ltd.
  • LeMaitre Vascular Inc.
  • Life Cell Corporation
  • LifeNet Health
  • LivaNova, PLC
  • Medical Devices Business Services, Inc.
  • Medtronic PLC
  • Organogenesis, Inc.
  • Sorin Group
  • Suzhou Jiecheng Medical Technology Co., Ltd
  • Ziacom Medical
Product Code: MRR-3E42F39F1CF4

The Bioprosthetics Market was valued at USD 5.97 billion in 2023, expected to reach USD 7.14 billion in 2024, and is projected to grow at a CAGR of 19.61%, to USD 20.94 billion by 2030.

Bioprosthetics encompass a segment of medical implants made from biological materials, designed to replace or repair damaged tissues or organs. Their necessity arises from issues like degenerative diseases, trauma, and congenital defects, leading to the demand for more compatible and less rejection-prone substitutes compared to traditional materials. Applications primarily include cardiovascular surgeries, particularly heart valves, hernia repair, and other soft tissue reconstructions. The end-use sectors are vast, spanning hospitals, specialty clinics, and ambulatory surgical centers, which are continually challenged to improve patient outcomes with advanced surgical options. Key growth drivers include the increasing prevalence of cardiovascular diseases, advancements in biocompatibility, and the aging population, which is more prone to conditions requiring such interventions. Emerging markets offer enormous potential due to an increasing focus on healthcare infrastructure development and rising patient awareness about advanced treatment options. However, limitations such as high costs, stringent regulatory environments, and ethical concerns related to the use of biological materials can hamper market progress. Challenges also stem from intense competition and technological constraints in synthetic alternatives that developers must surpass. Innovating in areas like tissue engineering, enhanced materials biocompatibility, and combination devices integrating digital health tools can provide lucrative opportunities for business growth. Research in improving durability and reducing immunogenicity is crucial for expanding market acceptance and applicability. The market is inherently dynamic, driven by regulatory shifts and technological advancements globally. Companies should invest in R&D for cutting-edge bioprosthetic solutions and collaborate with healthcare providers to ensure that products meet current and emerging needs. Building awareness and proving safety and efficacy through clinical trials are essential strategies to fortify market position.

KEY MARKET STATISTICS
Base Year [2023] USD 5.97 billion
Estimated Year [2024] USD 7.14 billion
Forecast Year [2030] USD 20.94 billion
CAGR (%) 19.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprosthetics Market

The Bioprosthetics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiovascular diseases among population
    • Increase in healthcare expenditure in economies
    • Significant applications of bioprosthetics in plastic surgery & wound healing procedures
  • Market Restraints
    • High costs associated with bioprosthetic surgeries
  • Market Opportunities
    • Technological advancement and rapid evolution of tissue-engineered bioprostheses
    • Emerging funding activities to boost research and development activities
  • Market Challenges
    • Issues pertaining to valve durability and compatibility

Porter's Five Forces: A Strategic Tool for Navigating the Bioprosthetics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprosthetics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprosthetics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprosthetics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprosthetics Market

A detailed market share analysis in the Bioprosthetics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprosthetics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprosthetics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprosthetics Market

A strategic analysis of the Bioprosthetics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprosthetics Market, highlighting leading vendors and their innovative profiles. These include Anteris Technologies Ltd., Aortech International PLC, Boston Scientific Corporation, Braile Biomedica, Inc., Corcym UK Limited, Edwards Lifesciences Corporation, Foldax, Getinge AB, Hancock Jaffe Laboratories, Inc., Humacyte, Inc., JenaValve Technology GmbH, Labcor Laboratorios Ltd., LeMaitre Vascular Inc., Life Cell Corporation, LifeNet Health, LivaNova, PLC, Medical Devices Business Services, Inc., Medtronic PLC, Organogenesis, Inc., Sorin Group, Suzhou Jiecheng Medical Technology Co., Ltd, and Ziacom Medical.

Market Segmentation & Coverage

This research report categorizes the Bioprosthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Allograft, Bovine, Porcine, and Xenograft.
  • Based on Application, market is studied across Cardiovascular and Plastic Surgery & Wound Healing.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiovascular diseases among population
      • 5.1.1.2. Increase in healthcare expenditure in economies
      • 5.1.1.3. Significant applications of bioprosthetics in plastic surgery & wound healing procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with bioprosthetic surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement and rapid evolution of tissue-engineered bioprostheses
      • 5.1.3.2. Emerging funding activities to boost research and development activities
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to valve durability and compatibility
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprosthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Allograft
  • 6.3. Bovine
  • 6.4. Porcine
  • 6.5. Xenograft

7. Bioprosthetics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Plastic Surgery & Wound Healing

8. Americas Bioprosthetics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bioprosthetics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bioprosthetics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anteris Technologies Ltd.
  • 2. Aortech International PLC
  • 3. Boston Scientific Corporation
  • 4. Braile Biomedica, Inc.
  • 5. Corcym UK Limited
  • 6. Edwards Lifesciences Corporation
  • 7. Foldax
  • 8. Getinge AB
  • 9. Hancock Jaffe Laboratories, Inc.
  • 10. Humacyte, Inc.
  • 11. JenaValve Technology GmbH
  • 12. Labcor Laboratorios Ltd.
  • 13. LeMaitre Vascular Inc.
  • 14. Life Cell Corporation
  • 15. LifeNet Health
  • 16. LivaNova, PLC
  • 17. Medical Devices Business Services, Inc.
  • 18. Medtronic PLC
  • 19. Organogenesis, Inc.
  • 20. Sorin Group
  • 21. Suzhou Jiecheng Medical Technology Co., Ltd
  • 22. Ziacom Medical

LIST OF FIGURES

  • FIGURE 1. BIOPROSTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROSTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROSTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROSTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROSTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROSTHETICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROSTHETICS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROSTHETICS MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROSTHETICS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROSTHETICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROSTHETICS MARKET SIZE, BY PLASTIC SURGERY & WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BIOPROSTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BIOPROSTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BIOPROSTHETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. BIOPROSTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BIOPROSTHETICS MARKET, FPNV POSITIONING MATRIX, 2023